These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 28634044

  • 1. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M, Zeng C, Lu X, He X, Zhang R, Qiu Q, Zheng G, Jia X, Liu H, He Z.
    Cancer Lett; 2017 Sep 10; 403():175-185. PubMed ID: 28634044
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
    Wang Y, Zhou X, Shan B, Han J, Wang F, Fan X, Lv Y, Chang L, Liu W.
    Mol Med Rep; 2015 Nov 10; 12(5):6491-500. PubMed ID: 26352175
    [Abstract] [Full Text] [Related]

  • 3. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F, Mao A, Tang J, Zhang Q, Yan J, Wang Y, Di C, Gan L, Sun C, Zhang H.
    J Cell Physiol; 2019 Aug 10; 234(8):13182-13190. PubMed ID: 30536619
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B, Zhao Z, Wang Z, Li Q, Wang X, Wang W, Song T, Huang C.
    Cell Physiol Biochem; 2017 Aug 10; 42(4):1701-1711. PubMed ID: 28743112
    [Abstract] [Full Text] [Related]

  • 5. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B, Yang S, Liu T, Lou G.
    Mol Cancer; 2015 Mar 11; 14():57. PubMed ID: 25889927
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B, Zhao Q, Guan L, Lv H, Bie L, Huang J, Chen XB.
    J Cell Mol Med; 2018 Oct 11; 22(10):4751-4759. PubMed ID: 30006956
    [Abstract] [Full Text] [Related]

  • 7. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
    He J, Ge Q, Lin Z, Shen W, Lin R, Wu J, Wang B, Lu Y, Chen L, Liu X, Zheng W, Zhang Y, Wang L, Wang K, Wang L, Zhuo W, Chen S.
    FASEB J; 2020 Jun 11; 34(6):8544-8557. PubMed ID: 32356314
    [Abstract] [Full Text] [Related]

  • 8. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
    Huang TT, Ping YH, Wang AM, Ke CC, Fang WL, Huang KH, Lee HC, Chi CW, Yeh TS.
    Oncotarget; 2015 Jul 20; 6(20):18012-26. PubMed ID: 26041881
    [Abstract] [Full Text] [Related]

  • 9. Growth inhibitory effects of three miR-129 family members on gastric cancer.
    Yu X, Song H, Xia T, Han S, Xiao B, Luo L, Xi Y, Guo J.
    Gene; 2013 Dec 10; 532(1):87-93. PubMed ID: 24055727
    [Abstract] [Full Text] [Related]

  • 10. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
    Feng L, Xie Y, Zhang H, Wu Y.
    Med Oncol; 2012 Jun 10; 29(2):856-63. PubMed ID: 21264532
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
    Xu YY, Song YQ, Huang ZM, Zhang HB, Chen M.
    Kaohsiung J Med Sci; 2019 May 10; 35(5):277-283. PubMed ID: 30897301
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
    Shin SS, Park SS, Hwang B, Moon B, Kim WT, Kim WJ, Moon SK.
    Oncol Rep; 2016 Oct 10; 36(4):2313-20. PubMed ID: 27573859
    [Abstract] [Full Text] [Related]

  • 13. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.
    Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M, Yu Q.
    Genes Dev; 2009 Oct 15; 23(20):2388-93. PubMed ID: 19833767
    [Abstract] [Full Text] [Related]

  • 14. LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating ADCY3.
    Zou J, Wu K, Lin C, Jie ZG.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G10-G22. PubMed ID: 31433213
    [Abstract] [Full Text] [Related]

  • 15. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K, Tong Q.
    PLoS One; 2013 Jan 01; 8(1):e55719. PubMed ID: 23383271
    [Abstract] [Full Text] [Related]

  • 16. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.
    Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D.
    PLoS Genet; 2010 Mar 12; 6(3):e1000879. PubMed ID: 20300657
    [Abstract] [Full Text] [Related]

  • 17. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J, Fang Y, Cao Y, Qin R, Chen Q.
    Dig Dis Sci; 2014 Feb 12; 59(2):336-45. PubMed ID: 24248414
    [Abstract] [Full Text] [Related]

  • 18. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
    Bao C, Chen J, Chen D, Lu Y, Lou W, Ding B, Xu L, Fan W.
    Cell Death Dis; 2020 Aug 14; 11(8):618. PubMed ID: 32796817
    [Abstract] [Full Text] [Related]

  • 19. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
    Wang S, Wang X, Gao Y, Peng Y, Dong N, Xie Q, Zhang X, Wu Y, Li M, Li JL.
    J Pathol; 2019 Jun 14; 248(2):204-216. PubMed ID: 30714150
    [Abstract] [Full Text] [Related]

  • 20. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
    Guo Z, Lv X, Jia H.
    Hum Cell; 2020 Jul 14; 33(3):759-767. PubMed ID: 32266659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.